Grown Rogue International (GRUSF) Capital Expenditures (2018 - 2026)
Grown Rogue International (GRUSF) posted quarterly Capital Expenditures of $2.5 million for Q1 2026, up 942.27% year-over-year from $241532.0 in Q1 2025, and down 100.0% quarter-over-quarter from $1056.5 billion in Q4 2025.
Grown Rogue International (GRUSF) Capital Expenditures (2018 - 2026) Analysis & Trends
Grown Rogue International's Capital Expenditures history runs 9 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- In Q1 2026, Capital Expenditures rose 942.27% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $6.9 million (up 50.07% YoY), while the FY2025 annual figure was $4.7 million, up 14.13% from the prior year.
- Capital Expenditures for Q1 2026 stood at $2.5 million, down from $1056.5 billion in the prior quarter.
- The five-year high for Capital Expenditures was $1267.5 billion in Q4 2024, with the low at -$1267.5 billion in Q3 2024.
- The 5-year median for Capital Expenditures is -$297314.0 (2024), against an average of $548372.8.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures sank 461.34% in 2022, then jumped 1000503556.29% in 2024.
- Grown Rogue International's Capital Expenditures stood at -$574595.0 in 2022, then jumped by 122.05% to $126690.0 in 2023, then surged by 1000503556.29% to $1267.5 billion in 2024, then dropped by 16.65% to $1056.5 billion in 2025, then plunged by 100.0% to $2.5 million in 2026.
- Business Quant data shows GRUSF's Capital Expenditures at $2.5 million in Q1 2026, $1056.5 billion in Q4 2025, and -$1056.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Grown Rogue International | 109.32 Mn | 97.78 Mn | 5.37 Mn | 2.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.98 Mn |
| Jun 30, 2026 | 2.98 Mn |
| Mar 31, 2026 | 2.52 Mn |
| Mar 31, 2026 | 2.52 Mn |
| Dec 31, 2025 | 1,056.50 Bn |
| Dec 31, 2025 | 1,056.50 Bn |
| Sep 30, 2025 | -1,056.50 Bn |
| Sep 30, 2025 | -1,056.50 Bn |
| Jun 30, 2025 | -773,726.00 |
| Jun 30, 2025 | -773,726.00 |
| Mar 31, 2025 | 241,532.00 |
| Mar 31, 2025 | 241,532.00 |
| Dec 31, 2024 | 1,267.54 Bn |
| Dec 31, 2024 | 1,267.54 Bn |
| Sep 30, 2024 | -1,267.53 Bn |
| Sep 30, 2024 | -1,267.53 Bn |
| Jun 30, 2024 | -230,497.00 |
| Jun 30, 2024 | -230,497.00 |
| Mar 31, 2024 | -297,314.00 |
| Mar 31, 2024 | -297,314.00 |